Magnetic Resonance Spectroscopy in Chronic Epilepsy
The cornerstone of lesion detection in chronic epilepsy is structural imaging, mainly magnetic resonance imaging. Metabolic information from magnetic resonance spectroscopy (MRS) might serve as an additional or as a surrogate marker for the epileptogenic lesion. MRS might also help to differentiate similarly appearing lesions from one another; it might detect contralateral/remote dysfunction. However, the clinical role of MRS is unclear, albeit another non-invasive diagnostic tool.
KeywordsMagnetic Resonance Spectroscopy Hippocampal Sclerosis Focal Cortical Dysplasia Neuronal Ceroid Lipofuscinoses Juvenile Myoclonic Epilepsy
- Burch J, Hinde S, Palmer S et al (2012) The clinical effectiveness and costeffectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model. Health Technol Assess 16(34):1–164PubMedGoogle Scholar
- McLean MA, Koepp M, Woermann FG (2008) Magnetic resonance spectroscopy in patients with epilepsy. In: Lüders H (ed) Textbook of epilepsy Surgery. Informa Healthcare, London Google Scholar